Fact CheckerSign in

NCT07476859RecruitingPhase 4

Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome

Source: ClinicalTrials.gov · Last updated 24 Mar 2026

Brief summary (registry, in English)

The goal of this phase IV, open-label, randomized clinical trial is to evaluate whether intravenous iron improves quality of life in adults aged 65 years and older with iron deficiency after an acute coronary syndrome (ACS). The main questions it aims to answer are: * Does intravenous iron improve quality of life at 6 and 12 months? * Does it reduce frailty and adverse clinical outcomes? Researchers will compare intravenous ferric carboxymaltose with standard of care. Participants will: * Be randomly assigned to receive intravenous iron or standard care * Attend three study visits over 12 months * Complete questionnaires and undergo blood tests

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
538 (estimated)
First submitted
2 Mar 2026
Start date
5 Mar 2026
Primary completion date
Apr 2028
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
NCT number
NCT07476859

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 538
  • From 5 Mar 2026 to the primary completion date, Apr 2028
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior treatment with intravenous or oral iron within 12 months before the index ACS.

Other illness

  • Active malignancy.
  • End-stage or terminal illness as determined by the IDC-Pal score.
  • Chronic dialysis or advanced renal or hepatic failure.
  • Known hypersensitivity to ferric carboxymaltose, other parenteral iron products, or any component of the formulation.
  • Evidence of iron overload or disorders of iron metabolism.
  • Ongoing bacteremia or active systemic infection.
  • Any condition that, in the investigator's opinion, would compromise safety, protocol compliance, or study integrity.

Lab values

  • Known heart failure with left ventricular ejection fraction (LVEF) \< 40% prior to enrollment, or development of LVEF \< 40% during hospitalization or within 15 days after ACS.
  • Severe anemia (hemoglobin \< 10 g/dL) at the time of ACS or within 15 days after the event.

Other

  • Participation in another interventional clinical trial involving an investigational medicinal product.

Who the study is looking for

  • Age ≥ 65 years.
  • Hospitalization for confirmed acute coronary syndrome (ACS) within 15 days prior to enrollment.
  • Iron deficiency diagnosed at admission or within 15 days after the index ACS event, defined as:
    • Serum ferritin \< 100 ng/mL, OR
    • Transferrin saturation (TSAT) \< 20%.
  • Ability to provide written informed consent prior to participation.

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitario de Badajoz
Coordinator of this site? Confirm its status
BadajozSpainRecruiting
Hospital Clinic de Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainNot yet recruiting
Hospital Clínico Universitario Virgen de la Arrixaca
Coordinator of this site? Confirm its status
El PalmarSpainRecruiting
Hospital Universitario Clínico San Cecilio
Coordinator of this site? Confirm its status
GranadaSpainRecruiting
Hospital Universitario De Leon
Coordinator of this site? Confirm its status
LeónSpainNot yet recruiting
Hospital Clínico San Carlos
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario de Navarra
Coordinator of this site? Confirm its status
PamplonaSpainNot yet recruiting
Hospital Clinico Universitario de Valencia
Coordinator of this site? Confirm its status
ValenciaSpainRecruiting
Hospital Alvaro Cunqueiro
Coordinator of this site? Confirm its status
VigoSpainNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.